4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-047908
President sold 25,000 shares at $100.00 ($2,500,000)
- President acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novak Rodger President | 2020-08-19 | Option exercise | +25,000 | $14.00 | $350,000 | 673,007 | D: show line 1 in the form |
| Novak Rodger President | 2020-08-19 | Sale | −25,000 | $100.00 | $2,500,000 | 648,007 | D: show line 2 in the form |
| Open-market sales · 25,000 sh · avg $100.00 · $2,500,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novak Rodger President | 2020-08-19 | Option exercise · Stock Option (Right to Buy) | −25,000 | 115,826 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…